Tarceva Helps Keep Lung Cancer From Worsening

Lung cancer drug Tarceva was significantly better than a placebo in keeping the disease from worsening in patients whose cancer had not progressed after treatment with platinum-based chemotherapy, according to a late-stage clinical trial.
Interactive Investor